Patent ID: 11939370
Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 13:
14. A vaccine formulation comprising one or more antibodies or antibody fragments characterized by clone-paired heavy and light chain CDR sequences selected from
heavy chain CDR1-3 of SEQ ID NOs: 91, 92 and 93, and light chain CDR1-3 of SEQ ID NOs: 154, 155, and 156;
heavy chain CDR1-3 of SEQ ID NOs: 118, 119 and 120, and light chain CDR1-3 of SEO ID NOs: 181, 182, and 183; or
heavy chain CDR1-3 of SEQ ID NOs: 127, 128 and 129, and light chain CDR1-3 of SEQ ID NOs: 190, 191, and 192;, and a pharmaceutically acceptable carrier.